Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[fwb]

KTOV PRICE ACTION is HAPPENING because of the TRADERS (SWING, DAY)
buying in and Selling out.
Until there is SOLID NEWS about BMY and KTOV collaboration, there will be NO BIG MOVES
A COLLABORATION IS NOT A GUARANTEE. IF IT FAILS, KTOV WILL TAKE A DRIVE IN PRICE
The company will collaborate with Bristol-Myers Squibb (NYSE:BMY) on a Phase 1 study of CM-24 in combination with BMY's Opdivo (nivolumab) for non-small-cell lung carcinoma and pancreatic cancer. The study is expected to begin in Q4 with data expected in H1 2021.

The FDA has signed off on its IND for NT-219, as monotherapy or in combination with Erbitux, for the treatment of recurrent or metastatic solid tumors and head and neck cancer. Phase 1 data are expected in H1 2021.

Multiple data readouts are expected within 15 months

So right now it's the TRADERS that are moving KTOV